Echinacoside ameliorates hepatic fibrosis and tumor invasion in rats with thioacetamide-induced hepatocellular carcinoma
Biomolecules and Biomedicine · 2024
DOI: 10.17305/bb.2024.10367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Ajwan Z Albalawi und 9 weiteren Autor:innen. Beteiligte Einrichtung: PharmD Program, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia. Hauptthemen laut MEDLINE: Thioacetamide, Carcinoma, Hepatocellular, Liver Cirrhosis, Glycosides. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) affects approximately 800,000 individuals globally each year. Despite advancements in HCC treatments, there is still a pressing need to identify new drugs that can combat resistance. One potential option is echinacoside, a natural caffeic acid glycoside with antioxidant, anti-inflammatory, antidepressant, and antidiabetic properties. Therefore, we aimed to investigate the ability of echinacoside to exhibit antitumor activity against HCC in rats through ameliorating hepatic fibrosis and tumor invasion. Rats were given thioacetamide to induce HCC, and some were given 30 mg/kg of echinacoside twice a week for 16 weeks. The liver impairment was assessed by measuring serum α-fetoprotein (AFP) and examining liver sections stained with Masson trichrome or anti-transforming growth factor (TGF)-β1 antibodies. The hepatic expression of mRNA and protein levels of TGF-β1, β-catenin, SMAD4, matrix metalloproteinase-9 (MMP9), phosphoinositide 3-kinases (PI3K), mammalian target of rapamycin (mTOR), connective tissue growth factor 2 (CCN2), E-Cadherin, platelets derived growth factor (PDGF)-B and fascin were also analyzed. Echinacoside improved the survival rate of rats by decreasing serum AFP and the number of hepatic nodules. Examination of micro-images indicated that echinacoside can reduce fibrosis. It also significantly decreased the expression of TGF-β1, β-catenin, SMAD4, MMP9, PI3K, mTOR, CCN2, PDGF-B, and fascin while enhancing the expression of E-Cadherin. In conclusion, echinacoside exhibits a protective effect against HCC by increasing survival rates and decreasing tumor growth. It also acts as an inhibitor of the hepatic tissue fibrosis pathway by reducing the expression of TGF-β1, β-catenin, SMAD4, PI3K, CCN2, PDGF-B and mTOR. Additionally, it prevents tumor invasion by suppressing MMP9 and fascin, and increasing the expression of E-Cadherin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- PharmD Program, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
- Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa City, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
Zitieren
APA
Albalawi, A. Z., Alatawi, A. S., Al-Atwi, S. M., Alhwyty, L. S., Alharbi, K. M., Alshehri, S. A., Almarwani, W. A., Aljohani, K. K., Hassan, H. M., & Al-Gayyar, M. M. H. (2024). Echinacoside ameliorates hepatic fibrosis and tumor invasion in rats with thioacetamide-induced hepatocellular carcinoma. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.10367
Vancouver
Albalawi AZ, Alatawi AS, Al-Atwi SM, Alhwyty LS, Alharbi KM, Alshehri SA, et al. Echinacoside ameliorates hepatic fibrosis and tumor invasion in rats with thioacetamide-induced hepatocellular carcinoma. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.10367
BibTeX
@article{Albalawi2024,
author = {Albalawi, Ajwan Z and Alatawi, Areej S and Al-Atwi, Shekha M and Alhwyty, Lama S and Alharbi, Kadi M and Alshehri, Shahad A and Almarwani, Wasayf A and Aljohani, Khulud K and Hassan, Hanan M and Al-Gayyar, Mohammed M H},
title = {Echinacoside ameliorates hepatic fibrosis and tumor invasion in rats with thioacetamide-induced hepatocellular carcinoma},
journal = {Biomolecules and Biomedicine},
year = {2024},
doi = {10.17305/bb.2024.10367}
}
EUVIMED